Status:
COMPLETED
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to assess the relative biological availability and the effect of food on the drug levels of Danicamtiv in health adults.
Eligibility Criteria
Inclusion
- Body mass index (BMI) of 18.0 kg/m2 to 30.0 kg/m2 inclusive
- Participants with resting heart rate ≥ 55 bpm
- Seasonal allergies that do not require medication at the time of the study are acceptable
Exclusion
- Any acute or chronic medical illness
- Head injury, intracranial tumor, or aneurysm within 2 years prior to screening
- History of chronic gastrointestinal disorders or gastrointestinal (GI) surgery (including cholecystectomy) that could impact on drug and food absorption and/or drug excretion
Key Trial Info
Start Date :
September 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 10 2023
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT06027437
Start Date
September 5 2023
End Date
November 10 2023
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anaheim Clinical Trials
Anaheim, California, United States, 92801